Tyra Biosciences (NASDAQ:TYRA) Given Outperform Rating at Oppenheimer
Oppenheimer restated their outperform rating on shares of Tyra Biosciences (NASDAQ:TYRA – Free Report) in a research report report published on Monday, Benzinga reports. Oppenheimer currently has a $28.00 price target on the stock, up from their previous price target of $25.00. A number of other brokerages have also weighed in on TYRA. Wedbush restated […]
More Stories
Duke Energy Co. (DUK) to Issue Quarterly Dividend of $1.05 on March 17th
Duke Energy Co. (NYSE:DUK – Get Free Report) declared a quarterly dividend on Thursday, January 9th,RTT News reports. Shareholders of...
Greggs (LON:GRG) Trading Down 14.6% – Should You Sell?
Greggs plc (LON:GRG – Get Free Report) traded down 14.6% on Thursday . The company traded as low as GBX...
PepsiCo (NASDAQ:PEP) Trading 0.8% Higher – Should You Buy?
PepsiCo, Inc. (NASDAQ:PEP – Get Free Report)’s stock price shot up 0.8% during mid-day trading on Thursday . The stock...
Constellation Brands (NYSE:STZ) Releases FY25 Earnings Guidance
Constellation Brands (NYSE:STZ – Get Free Report) updated its FY25 earnings guidance on Friday. The company provided earnings per share...
Bobcoin (BOBC) Price Hits $0.58 on Major Exchanges
Bobcoin (BOBC) traded flat against the US dollar during the one day period ending at 7:00 AM E.T. on January...
Environmental Tectonics (OTCMKTS:ETCC) Releases Earnings Results
Environmental Tectonics (OTCMKTS:ETCC – Get Free Report) posted its quarterly earnings results on Friday. The aerospace company reported $0.14 earnings...